The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Smoking cessation interventions for smokers with current or past depression
Open accessAbstract
BACKGROUND: Individuals with current or past depression are often smokers who are more nicotine dependent, more likely to suffer from negative mood changes after nicotine withdrawal, and more likely to relapse to smoking after quitting than the general population, which contributes to their higher morbidity and mortality from smoking-related illnesses. It remains unclear what interventions can help them to quit smoking. OBJECTIVES: To evaluate the effectiveness of smoking cessation interventions, with and without specific mood management components, in smokers with current or past depression. SEARCH METHODS: In April 2013, we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO, other reviews, and asked experts for information on trials. SELECTION CRITERIA: Criteria for including studies in this review were that they had to be randomised controlled trials (RCTs) comparing smoking cessation interventions in adult smokers with current or past depression. Depression was defined as major depression or depressive symptoms. We included studies where subgroups of participants with depression were identified, either pre-stated or post hoc. The outcome was abstinence from smoking after six months or longer follow-up. We preferred prolonged or continuous abstinence and biochemically validated abstinence where available. DATA COLLECTION AND ANALYSIS: When possible, we estimated pooled risk ratios (RRs) with the Mantel-Haenszel method (fixed-effect model). We also performed subgroup analyses, by length of follow-up, depression measurement, depression group in study, antidepressant use, published or unpublished data, format of intervention, level of behavioural support, additional pharmacotherapy, type of antidepressant medication, and additional nicotine replacement therapy (NRT). MAIN RESULTS: Forty-nine RCTs were included of which 33 trials investigated smoking cessation interventions with specific mood management components for depression. In smokers with current depression, meta-analysis showed a significant positive effect for adding psychosocial mood management to a standard smoking cessation intervention when compared with standard smoking cessation intervention alone (11 trials, N = 1844, RR 1.47, 95% CI 1.13 to 1.92). In smokers with past depression we found a similar effect (13 trials, N = 1496, RR 1.41, 95% CI 1.13 to 1.77). Meta-analysis resulted in a positive effect, although not significant, for adding bupropion compared with placebo in smokers with current depression (5 trials, N = 410, RR 1.37, 95% CI 0.83 to 2.27). There were not enough trial data to evaluate the effectiveness of fluoxetine and paroxetine for smokers with current depression. Bupropion (4 trials, N = 404, RR 2.04, 95% CI 1.31 to 3.18) might significantly increase long-term cessation among smokers with past depression when compared with placebo, but the evidence for bupropion is relatively weak due to the small number of studies and the post hoc subgroups for all the studies. There were not enough trial data to evaluate the effectiveness of fluoxetine, nortriptyline, paroxetine, selegiline, and sertraline in smokers with past depression.Twenty-three of the 49 trials investigated smoking cessation interventions without specific components for depression. There was heterogeneity between the trials which compared psychosocial interventions with standard smoking cessation counselling for both smokers with current and past depression. Therefore, we did not estimate a pooled effect. One trial compared nicotine replacement therapy (NRT) versus placebo in smokers with current depression and found a positive, although not significant, effect (N = 196, RR 2.64, 95% CI 0.93 to 7.45). Meta-analysis also found a positive, although not significant, effect for NRT versus placebo in smokers with past depression (3 trials, N = 432, RR 1.17, 95% CI 0.85 to 1.60). Three trials compared other pharmacotherapy versus placebo and six trials compared other interventions in smokers with current or past depression. Due to heterogeneity between the interventions of the included trials we did not estimate pooled effects. AUTHORS' CONCLUSIONS: Evidence suggests that adding a psychosocial mood management component to a standard smoking cessation intervention increases long-term cessation rates in smokers with both current and past depression when compared with the standard intervention alone. Pooled results from four trials suggest that use of bupropion may increase long-term cessation in smokers with past depression. There was no evidence found for the use of bupropion in smokers with current depression. There was not enough evidence to evaluate the effectiveness of the other antidepressants in smokers with current or past depression. There was also not enough evidence to evaluate the group of trials that investigated interventions without specific mood management components for depression, including NRT and psychosocial i
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“given evidence that mood management improves smoking abstinence compared with standard smoking cessation support alone [35].”
From intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi-centre, acceptability and feasibility trial with nested qualitative methods (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The population was representative of IAPT service users in sex, age and education and participants with common mental illness from other RCTs of smoking cessation interventions [35].”
From intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi-centre, acceptability and feasibility trial with nested qualitative methods (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“van der Meer and colleagues conducted a Cochrane review of smoking cessation treatments for people with current and historical depression [21] and found that adding psychosocial mood management to usual smoking cessation treatment (e.g., nicotine replacement therapy) moderately increased cessation rates when compared to usual smoking treatment alone (risk ratio of 1.47; 95% confidence interval 1.13 to 1.92) [21],”
In the citing paper
“found that adding psychosocial mood management to usual smoking cessation treatment (e.g., nicotine replacement therapy) moderately increased cessation rates when compared to usual smoking treatment alone (risk ratio of 1.47; 95% confidence interval 1.13 to 1.92) [21]”
In the citing paper
“Studies in patients with severe mental disorders or alcoholism have shown that treating addiction and mental health in parallel results in meaningful improvements in both [17–21].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Treating Tobacco Use and Dependence: 2008 Update
Panel, T. U. A. D. G. (2008) · PsycEXTRA Dataset · doi:10.1037/e566222009-001 · Cited by 3,864
Treating tobacco use and dependence-Clinical practice guideline
Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,470
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,262
Research works printed but not linked: 14
- Lenert, 2004, Automated E-mail messaging as a tool for improving quit rates in an internet smoking cessation intervention, Journal of the American Medical Informatics Association, 11, 235, 10.1197/jamia.M1464 · DOI
- Lenert, 2003, Design and pilot evaluation of an internet smoking cessation program, Journal of the American Medical Informatics Association, 10, 16, 10.1197/jamia.M1128 · DOI
- Muñoz, 2006, Toward evidence-based internet interventions: A Spanish/English Web site for international smoking cessation trials, Nicotine & Tobacco Research, 8, 77, 10.1080/14622200500431940 · DOI · Paper page
- Csonka, 2008, The combination of targeted cognitive-behavioural psychotherapy and pharmacotherapy for patients suffering from depression in smoking cessation, International Journal of Neuropsychopharmacology, 11 Suppl 1, 92
- Ziedonis, 1997, Motivational enhancement therapy and nicotine replacement improve smoking cessation outcomes for smokers with schizophrenia or depression (SRNT Conference Summary), Addiction, 92, 633
- Blalock, 2008, Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment, Psychology of Addictive Behaviors, 22, 122, 10.1037/0893-164X.22.1.122 · DOI
- Brown, 2001, Cognitive-behavioral treatment for depression in smoking cessation, Journal of Consulting and Clinical Psychology, 69, 471, 10.1037/0022-006X.69.3.471 · DOI
- Evins AE Treating smokers with mental illness: toward best practices Conference SRNT Europe - Helsinki, Clinical theme lecture 2012
- Kahler, 2002, Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder, Journal of Abnormal Psychology, 111, 670, 10.1037/0021-843X.111.4.670 · DOI · Paper page
- Patten, 1998, Effectiveness of cognitive-behavioral therapies for smokers with histories of alcohol dependence and depression, Journal of Studies on Alcohol, 59, 327, 10.15288/jsa.1998.59.327 · DOI
- Prochaska, 2008, Treating tobacco dependence in clinically depressed smokers: Effect of smoking cessation on mental health functioning, American Journal of Public Health, 98, 446, 10.2105/AJPH.2006.101147 · DOI
- Thorsteinsson, 2001, The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression, Neuropsychopharmacology, 24, 350, 10.1016/S0893-133X(00)00217-7 · DOI
- Torres, 2010, Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions, Psychological Medicine, 40, 441, 10.1017/S0033291709990560 · DOI
- Tsoh, 2000, Development of major depression after treatment for smoking cessation, The American Journal of Psychiatry, 157, 368, 10.1176/appi.ajp.157.3.368 · DOI
Cited by
Sorted by citations
Items 101–159 of 159
Loree, A. M., Ondersma, S. J., & Grekin, E. R. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw262 · Cited by 5
Rosa, G. R. M. L., Giovane, C. D., Pedullá, E., Kowalski, J., Chapple, I., Minozzi, S., Amaliya, A., & Polosa, R. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02839-7 · Cited by 4
“Studies that recruited adults with mental health problems [28, 29], neurological disorders, alcohol or other drugs/substances consumers, nonsmoking population, and pregnant women [30] will be excluded.”
“It's the one thing they have left”: smoking, smoking cessation and mental health
Stockings, E., Metse, A. P., & Taylor, G. M. J. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10003420 · Cited by 4
Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms
Zhang, H., Gilbert, E., Hussain, S., Veldhuizen, S., Foll, B. L., Selby, P. L., & Zawertailo, L. A. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac288 · Cited by 5
Huang, S., Wahlquist, A. E., & Dahne, J. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2369155 · Cited by 5
“When compared to standard cessation interventions not tailored for depression, depression-specific interventions can improve cessation rates between 13% and 92% (see van der Meer et al., 2013 for review).”
Treatment of Tobacco Use Disorders in People with Mental Illness
Na, E., & Roh, S. (2015) · Journal of the Korean Society for Research on Nicotine and Tobacco · doi:10.25055/jksrnt.2015.6.2.78 · Cited by 4
“인하지 못하였으나, 표준적인 금연치료에 정신사회적 기분 증상 중재기법을 추가하는 것이 금연치료 단독에 비해 긍정 적인 영향을 주는 것으로 보고하였다.(48) 또한 우울증세를”
Gómez‐Gómez, I., Motrico, E., Moreno-Peral, P., Rigabert, A., Cerón, S. C., Ortega‐Calvo, M., Recio-Rodriguez, J. I., & Bellón, J. Á. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026842 · Cited by 4
Kidd, B., McCormack, J. C., Newcombe, D. A. L., Garner, K., O’Shea, A., & Humphrey, G. (2023) · medRxiv · doi:10.1101/2023.09.09.23295094 · Cited by 5
Taylor, G. M. J., Sawyer, K., Jacobsen, P., Freeman, T. P., Blackwell, A., Daryan, S., Metcalfe, C., Kessler, D., Munafò, M. R., & Aveyard, P. (2025) · Addiction · doi:10.1111/add.16718 · Cited by 2
Parul, P., Joseph, B., Datta, S., & Rahman, M. A. (2025) · Psychiatric Quarterly · doi:10.1007/s11126-025-10116-y · Cited by 3
“Many clinical and population-based studies have identified an association between smoking or nicotine addiction and various mental disorders like depression [36], schizophrenia [22], or bipolar affective disorder (BPAD) [24].”
Chu, C., Tzeng, N., Chang, H., Chang, C.-C., & Chen, T. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.07.008 · Cited by 3
“showed that bupropion may increase long-term cessation in smokers with a history of depression [7].”
BackgroundLeventhal, A. M. (2014) · Evidence-Based Mental Health · doi:10.1136/eb-2013-101573 · Cited by 3
Updated information on smoking cessation management
Choi, M.-K., & Paek, Y. (2016) · Journal of Korean Medical Association · doi:10.5124/jkma.2016.59.11.872 · Cited by 3
Sotiriou, I., Chalkiadaki, K., Nikolaidis, C., Sidiropoulou, K., & Chatzaki, Ε. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.02.082 · Cited by 3
Effects of Depression and Anxiety Scores on Smoking Cessation Treatment
Solak, İ., Yıldırım, D. İ., Gümüş, F., Eren, İ., & Eryılmaz, M. A. (2018) · Konuralp Tıp Dergisi · doi:10.18521/ktd.351519 · Cited by 3
Budenz, A., Wiseman, K. P., Keefe, B., & Prutzman, Y. M. (2022) · Health Education & Behavior · doi:10.1177/10901981211073736 · Cited by 2
“A review of 45 smoking cessation clinical trials found that integrating mood management support into smoking cessation interventions can facilitate successful quitting (examined mostly traditional treatment modalities with few mobile/digital programs) (van der Meer et al., 2013).”
BackgroundSzerman, N., Carlos, P., Pinet, C., Martínez-Raga, J., Basurte, I., & Sáiz, P. A. (2022) · Actas Españolas de Psiquiatría · Cited by 4
Uikey, M. S., & Dayal, P. (2023) · Cureus · doi:10.7759/cureus.37688 · Cited by 3
“[28], smokers with current depression showed an improvement in tobacco cessation when standard smoking cessation interventions were combined with management of adverse mood states.”
BackgroundDepression among smokers of a web-based intervention to quit smoking: a cross-sectional study
Gomide, H. P., Centro de Ensino Superior de Juiz de Fora, J. D. F., de Carvalho, C. R. T., Menezes, M. L., de Oliveira, I. G., de Mendonça, R. G. F., Júnior, R. D. D. A., Machado, N. M., Ervilha, R. R., da Rocha, T. C. R., et al. (2017) · Salud Mental · doi:10.17711/sm.0185-3325.2017.035 · Cited by 3
Extended Nicotine Patch Treatment Among Smokers With and Without Comorbid Psychopathology
Carroll, A. J., Mathew, A. R., Leone, F. T., Wileyto, E. P., Miele, A., Schnoll, R. A., & Hitsman, B. L. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty191 · Cited by 3
“664 Sexual orientation, sexual minority, N (%) 29 (7) 14 (12) .”
A simple test to assess the emotional status of smokers
Monteschi, M., de Pádua, A. I., Perez, C. R., Castellano, M. V. C. D. O., Cedano, S., Rodrigues, A. L., & Martínez, J. A. B. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12964 · Cited by 3
Elucidating directionality between smoking and depression
Carroll, A. J. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109790 · Cited by 3
Taylor, G. M. J., Aveyard, P. N., der Meer, R. V., Toze, D., Stuijfzand, B. G., Kessler, D. S., & Munafo, M. R. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018617 · Cited by 3
“Further investigation into these potential modifiers will provide useful information for development of smoking cessation interventions for people with current depression.(9) In addition, the review did not examine the impact of behavioural or psychological smoking cessation interventions on depression symptoms.”
InfluentialFan, H., Song, F., Gu, H., Wang, J., Jia, G., Lu, M., Qian, J., Wang, L., Shen, J., & ren, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10742 · Cited by 2
Rogers, E., & Vargas, E. (2017) · Tobacco Control · doi:10.1136/tobaccocontrol-2016-053590 · Cited by 2
Outpatient interventions for smoking cessation and reduction for adults with a mental disorder
Stockings, E., Black, N., Bartlem, K. M., Metse, A. P., Regan, T. W., Bailey, J. M., Wolfenden, L., Wiggers, J., & Bowman, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013286 · Cited by 3
Update on pharmacotherapy for smoking cessation
Choi, H. S., & Kim, J. Y. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.3.216 · Cited by 2
“수 있겠지만, 우울증 환자에게 더 효과적인 금연 약물이라는 근거는 아직까지 부족하다[31].”
Eficácia de um protocolo hospitalar para cessação do tabagismo no pós-alta: um estudo longitudinal
do Amaral, L. M., Andrade, R. D. O., Lanzieri, I. O., Richter, K. P., de Macêdo, Â. C. D. A. D., & Leite, I. C. G. (2022) · Revista de Medicina · doi:10.11606/issn.1679-9836.v101i3e-188696 · Cited by 2
Blackwell, A. K. M., Daryan, S., Roy, D. R., Duffy, D. J., Hisler, G. C., Sawyer, K., Ainsworth, B., Richards, D., Hiscock, D., Papadakis, S., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107541 · Cited by 2
“A Cochrane review of smoking cessation interventions for people with depression found that adding psychosocial mood management to usual treatment increased cessation rates compared to usual treatment alone (RR:1.47[95%CI: 1.13 to 1.92]) [11].”
InfluentialLight Pollution Associated with Delayed Sleep Time: A Major Hygienic Problem in Saudi Arabia
Ahmed, H. G., Alogla, S. A., Ismael, R. M., Alqufayi, A. A., Alamer, S. O., Alshaya, H. K., & Alshammari, A. E. M. (2017) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2017.73012 · Cited by 2
Metse, A. P., Stockings, E., Bailey, J. M., Regan, T., Bartlem, K. M., Wolfenden, L., Taylor, G. M. J., Wiggers, J. H., & Bowman, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030646 · Cited by 2
Effectiveness of stop smoking interventions among adults: an overview of systematic reviewsPreprint
Hersi, M., Beck, A., Hamel, C., Esmaeilisaraji, L., Pussegoda, K., Austin, B., Ahmadzai, N., Pratt, M., Thuku, M., Yazdi, F., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3743616/v1 · Cited by 2
Interventions for smoking cessation in inpatient psychiatry settings
Plever, S., Kisely, S. R., Bonevski, B., Siskind, D. J., Yamazaki-Tan, J., Thaker, P., Vos, G., Kim, D., Guillaumier, A., & GARTNER, C. E. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015934 · Cited by 1
Hitsman, B. L., D'Eletto, M., Gollan, J. K., Schnoll, R. A., & Papandonatos, G. D. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112761 · Cited by 1
Comorbidity of Smoking with Psychiatric Disorders
Batra, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-45375-5_20 · Cited by 1
Smoke and ethanolic extract of nicotiana tabacum altered hippocampal histology and behaviour in mice
Adeniyi, P. A., & Ogundele, O. M. (2014) · Journal of Cell and Animal Biology · doi:10.5897/jcab10.048 · Cited by 1
Kushnir, V., Sproule, B. A., Zawertailo, L. A., Selby, P. L., Tyndale, R. F., Leatherdale, S. T., & Cunningham, J. A. (2016) · Tobacco Control · doi:10.1136/tobaccocontrol-2016-052994 · Cited by 1
Robinson, J. D., Karam‐Hage, M., Kypriotakis, G., Beneventi, D., Blalock, J. A., Cui, Y., González, R. O., Tayar, J. H., Chaftari, P. S., & Cinciripini, P. M. (2022) · American Journal on Addictions · doi:10.1111/ajad.13282 · Cited by 1
Andrade, R. D. O., Lanzieri, I. O., do Amaral, L. M., Santos, M. S., & Leite, I. C. G. (2021) · Principia Caminhos da Iniciação Científica · doi:10.34019/2179-3700.2021.v21.33884 · Cited by 1
La semaine motivationnelle : une nouvelle approche dans le sevrage tabagique
Hanssens, L. S., Lustygier, V., Ansseau, M., Thiebaut, I., & Thimpont, J. (2016) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2016.06.006 · Cited by 1
Treatment of Tobacco Use Disorder and Mood Disorders in Adolescents
Witt, D. R., & Patten, C. A. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0216-9 · Cited by 1
Pettey, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4306 · Cited by 1
Varenicline for Smoking Cessation: a Review
Rauniar, G. P., Mishra, A., & Sarraf, D. P. (2016) · Health Renaissance · doi:10.3126/hren.v12i3.15324
Smoke-free Parents: Providing a smoke-free future for parents and their children
van Schayck, M. T. E. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/434
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg012
Stein, K. F., Sawyer, K., Daryan, S., Allen, J. L., & Taylor, G. M. J. (2022) · medRxiv · doi:10.1101/2022.03.23.22272703
“12 effective but have not explored how and why they work (10).”
BackgroundMinian, N., Ahad, S., Zawertailo, L. A., Ravindran, A. V., de Oliveira, C., Baliunas, D. O., Mulder, C., & Selby, P. L. (2020) · doi:10.21203/rs.2.21301/v1
“At the beginning of the initiative, a Cochrane review on smoking cessation interventions for smokers with current and past depression(29), and a training manual with operational details about the initiative, were electronically shared with all HCPs.”
BackgroundWirth, N., Derlon, V., Michy, B., Peyrin-Biroulet, C., Martinet, Y., & Bouaziz, H. (2015) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(15)70754-1 · Cited by 1
Wirth, N., Derlon, V., Michy, B., Peyrin-Biroulet, C., Martinet, Y., & Bouaziz, H. (2015) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(15)70562-1
Behandlung von schädlichem und abhängigem Tabakkonsum
Andreas, S., Batra, A., Brüggmann, D., Geyer, D., Gohlke, H., Hering, T., Jähne, A., Jückstöck, J., Klein, M., Kotz, D., et al. (2022) · Springer eBooks · doi:10.1007/978-3-662-63679-4_4
Cognitive-behavioral therapy for tobacco use disorder in smokers with depression: A critical review
González‐Roz, A., Weidberg, S. E., & MacKillop, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85726-0.00031-4
Her, W., Jung, H., & Oh, Y. S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2184736
Suzin, J. B., Santomauro, A. C., Campos, F. J. B., Burgatti, J. C., & Matos, C. S. (2024) · Idaho semi-weekly world · doi:10.15406/ijcam.2024.17.00679
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg012.pub2
Chiappini, S., Sampogna, G., Ventriglio, A., Menculini, G., Ricci, V., Pettorruso, M., Volpe, U., & Martinotti, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2506463
“Your emphasis on the need for further research in psychological interventions for TUD in MDD patients also resonates with our understanding of the field [9].”
Taylor, G. M. J., Jacobsen, P. C., Blackwell, A. K. M., Daryan, S., Roy, D. R., Duffy, D. J., Hisler, G. C., Sawyer, K., Ainsworth, B., Hiscock, D., et al. (2025) · JMIR Mental Health · doi:10.2196/78424
“In addition, a systematic review of smoking cessation interventions for people with current or past depression found that adding psychosocial mood management, primarily cognitive behavioral therapy, enhanced quitting smoking compared with usual smoking cessation support [11].”
Mutukula, S., Gagne-Hatfield, T., & Dunbar, Z. R. (2026) · Medicines · doi:10.3390/medicines13020019
Metadata
- Authors
- van der Meer, R. M., Willemsen, M. C., Smit, F., & Cuijpers, P.
- Affiliations
- STIVORO, Dutch Expert Centre on Tobacco Control; The Hague Netherlands
- Maastricht University (NL)
- Trimbos Institute (NL)
- Vrije Universiteit Amsterdam (NL)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-08-21
- Volume
- 2013
- Issue
- 8
- Pages
- CD006102-CD006102
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1698788306
- Cited by
- 159
- References
- 199
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 14 · 2022: 10 · 2021: 14 · 2020: 7 · 2019: 10 · 2018: 13 · 2017: 15 · 2016: 18 · 2015: 19 · 2014: 12 · 2013: 6
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Multilingual Matters (Channel View Publications) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- smoking cessation, depression, mood management, nicotine dependence, nicotine withdrawal, relapse, bupropion, nicotine replacement therapy, antidepressants, psychosocial interventions, smoking abstinence, relapse prevention, smoking cessation pharmacotherapy, behavioral support, tobacco dependence treatment
- MeSH terms
- Adult, Major Depressive Disorder, Humans, Smoking, Randomized Controlled Trials as Topic, Smoking Cessation, Bupropion, Treatment Outcome, Antidepressive Agents, Second-Generation, Tobacco Use Cessation Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
